Regarding the mechanism of action of lenalidomide in 5q MDS cells, the protein degradation of both IKZF1 and CK1α was required for the anti-proliferative effect of lenalidomide7,37. The gene discussed is CSNK1A1; the disease is myelodysplastic syndrome.